Germline variants in POT1 have been described in familial melanoma [9,10,11,12], glioma [13], Li-Fraumeni-like syndrome [14], colorectal cancer [15], chronic lymphocytic leukemia [16], and Hodgkin lymphoma [17]. This evidence concerns the gene POT1 and central nervous system cancer.